COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Shield II

Purpose of Study

Assess the safety and efficacy of the HeartMate PHP in supporting patients with severe symptomatic coronary artery disease with diminished but stable cardiovascular function, who are undergoing elective or urgent high risk percutaneous coronary interventions (PCI) but are not candidates for coronary artery bypass graft (CABG) surgery.

Trial Status


Eligibility Criteria

At least 18 years of age, undergoing elective or urgent high-risk PCI procedure, indicated for a revascularization of at least one lesion in a coronary vessel or bypass graft

Duration of Participation

Approximately 90 days

Contact Name: Kendra Tuttle, RN

Contact Phone: 515-235-5102

Contact Email: